OncoMasTR assay for breast cancer featured in the Medical Independent
Prof. William Gallagher, OncoMark's Chief Scientific Officer, was interviewed for the Medical Independent in an article entitled 'Taking the fight to cancer' about progresses in cancer research in Ireland.
The article highlighted the OncoMasTR assay, currently being developed by OncoMark, as a new diagnostic for breast cancer.
The OncoMasTR assay will reduce the overtreatment of early stage breast cancer patients with chemotherapy (about 2/3 of patients do not need chemotherapy but are treated because it is difficult to determine who is at risk) and the associated risks and cost. The OncoMasTR assay is expected to be available for clinical use in 2 years.